Successful treatment of relapsed FLT3-mutated donor cell-derived MDS/AML with FLT3 inhibitor gilteritinib. - Kawano M; Kunimoto H; Izumi A; Adachi A; Miura A; Yokoyama C; Hasegawa K; Shirafuta M; Tanaka M; Sakuma T; Ohashi T; Takahashi H; et al. (Annals of hematology, 2026)